Bingham Osborn & Scarborough’s Livongo Health, Inc. Common Stock LVGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-5,451
Closed -$763K 173
2020
Q3
$763K Buy
5,451
+15
+0.3% +$1.83K 0.06% 76
2020
Q2
$409K Buy
+5,436
New +$285K 0.03% 99

Bingham Osborn & Scarborough's LVGO Position: Q4 2020 in Review

Bingham Osborn & Scarborough sold out of Livongo Health, Inc. Common Stock (LVGO) in Q4 2020, closing a stake of 5,451 shares — an estimated $763K sold.

Bingham Osborn & Scarborough first reported a position in LVGO in Q2 2020 and held it in 2 quarters. The position peaked at $763K in Q3 2020. 0 funds tracked by Wall St. Rank hold LVGO as of Q4 2020.

  • Bingham Osborn & Scarborough reported no remaining Livongo Health, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Bingham Osborn & Scarborough sold 5,451 Livongo Health, Inc. Common Stock shares in Q4 2020, an estimated $763K.
  • Bingham Osborn & Scarborough first reported a position in Livongo Health, Inc. Common Stock in Q2 2020 and held it in 2 quarters.
  • Bingham Osborn & Scarborough's Livongo Health, Inc. Common Stock position peaked at $763K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Livongo Health, Inc. Common Stock as of Q4 2020.

Based on Bingham Osborn & Scarborough's 13F filing for Q4 2020, filed 11 Feb 2021.